Literature DB >> 21285484

Cone-beam optical computed tomography for gel dosimetry II: imaging protocols.

Tim Olding1, L John Schreiner.   

Abstract

This work develops imaging protocols for improved dose readout of a Fricke-xylenol orange-gelatin (FXG) gel-filled 1 L polyethylene terephthalate (PETE) jar dosimeter using a commercial Vista(TM) cone-beam optical computed tomography (CT) scanner from Modus Medical Devices Inc. (London, ON, Canada). To ensure good management of light source-detector stability, it was determined that (a) a minimum of 2 h warm-up time is necessary prior to dosimeter scanning, (b) the light source should be kept on until the completion of the last data scan except for the minimum amount of time required to acquire dark field images, and (c) the optional Vista software projection image normalization routine should be used in image reconstruction. The institution of dosimeter scan time and temperature control was strongly indicated from the experiments. A standard post-irradiation wait time of 30 min measured to within ±30 s was established to minimize the measurement uncertainties due to dosimeter development and diffusion. To alleviate thermochromic behavior leading to inaccurate dose readout, holding bath warm up and pre-scan temperature adjustment procedures were developed to control dosimeter temperature to within ±0.2 °C. The possibility of stray light minimizing protocols was also investigated and deemed to be unnecessary. The largest significant sources of stray light in the system were identified as being due to angled scatter from the dosimeter gelatin matrix and refraction from the jar wall interfaces. It was concluded that these phenomena would be better addressed through dosimeter modification and an inter-jar dose-to-attenuation calibration methodology, rather than by setting additional imaging protocols.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21285484     DOI: 10.1088/0031-9155/56/5/003

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  7 in total

1.  Commissioning and benchmarking a 3D dosimetry system for clinical use.

Authors:  Andrew Thomas; Joseph Newton; John Adamovics; Mark Oldham
Journal:  Med Phys       Date:  2011-08       Impact factor: 4.071

2.  Optical cone beam tomography of Cherenkov-mediated signals for fast 3D dosimetry of x-ray photon beams in water.

Authors:  Adam K Glaser; Jacqueline M Andreozzi; Rongxiao Zhang; Brian W Pogue; David J Gladstone
Journal:  Med Phys       Date:  2015-07       Impact factor: 4.071

Review 3.  Optical and x-ray technology synergies enabling diagnostic and therapeutic applications in medicine.

Authors:  Brian W Pogue; Brian C Wilson
Journal:  J Biomed Opt       Date:  2018-10       Impact factor: 3.170

4.  Video-rate optical dosimetry and dynamic visualization of IMRT and VMAT treatment plans in water using Cherenkov radiation.

Authors:  Adam K Glaser; Jacqueline M Andreozzi; Scott C Davis; Rongxiao Zhang; Brian W Pogue; Colleen J Fox; David J Gladstone
Journal:  Med Phys       Date:  2014-06       Impact factor: 4.071

5.  Application of radiochromic gel dosimetry to commissioning of a megavoltage research linear accelerator for small-field animal irradiation studies.

Authors:  Noora Ba Sunbul; Ibrahim Oraiqat; Benjamin Rosen; Cameron Miller; Christopher Meert; Martha M Matuszak; Shaun Clarke; Sara Pozzi; Jean M Moran; Issam El Naqa
Journal:  Med Phys       Date:  2021-02-06       Impact factor: 4.071

6.  Investigating the effect of a magnetic field on dose distributions at phantom-air interfaces using PRESAGE® 3D dosimeter and Monte Carlo simulations.

Authors:  Filipa Costa; Simon J Doran; Ian M Hanson; Simeon Nill; Ilias Billas; David Shipley; Simon Duane; John Adamovics; Uwe Oelfke
Journal:  Phys Med Biol       Date:  2018-02-26       Impact factor: 3.609

7.  Fricke gel dosimeter with improved sensitivity for low-dose-level measurements.

Authors:  Mauro Valente; Wladimir Molina; Lila Carrizales Silva; Rodolfo Figueroa; Francisco Malano; Pedro Pérez; Mauricio Santibañez; José Vedelago
Journal:  J Appl Clin Med Phys       Date:  2016-07-08       Impact factor: 2.102

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.